Finerenone has shown benefits for patients with nondiabetic chronic kidney disease, with potential benefits for both kidney and cardiovascular health. The drug's effectiveness has been highlighted in multiple studies, which may expand its potential use to millions more patients. The exact scope of finerenone's benefits and the number of patients who could be helped are still being reported, with some outlets suggesting it could be beneficial for hundreds of millions of people.